The pharmaceutical industry is becoming increasingly complex as companies work to develop innovative therapies, accelerate development timelines, and meet growing healthcare needs worldwide. As a result, Contract Development and Manufacturing Organizations (CDMOs) are playing an increasingly important role in supporting pharmaceutical innovation. 

Today, a leading pharma company in India is contributing not only to medicine manufacturing but also to research, development, and commercialization activities for global pharmaceutical innovators. This shift is creating new opportunities for India to strengthen its position in the global pharmaceutical value chain. Against this backdrop, Piramal Pharma Limited continues to expand its CDMO capabilities to support the evolving needs of innovator pharmaceutical companies worldwide.